Similarly, LAG-3 is expressed on the surface of activated T cells and is emerging as an important IC in supressing several arms of the anti-tumour repertoire of immune cells and is garnering a lot of attention as a therapeutic target to reinvigorate exhausted T cells (Blackburn et al. 2009). This evidence concerns the gene LAG3 and neoplasm.